Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 482 clinical trials
featured
Atrial Fibrillation

of ischemic stroke or systemic embolism in subjects with non-valvular atrial fibrillation who have an appropriate rationale to seek a non-pharmacologic alternative to chronic oral anticoagulation.

vascular disease
anticoagulation therapy
heart failure
warfarin
aspirin
  • 618 views
  • 03 Dec, 2020
  • 1 location
featured
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 40 views
  • 25 Mar, 2021
  • 1 location
Imatinib in Acute Ischaemic Stroke

A clinical trial comparing treatment with Imatinib to placebo when administered within 8 hours of stroke onset for 6 days, in addition to conventional stroke treatment after acute ischaemic

  • 16 views
  • 25 Jan, 2021
  • 26 locations
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

The risk of early recurrence or progression of acute ischemic stroke is very high, even in patients treated with aspirin. The Chance study show that clopidogrel plus aspirin treatment reduced

clopidogrel
deficit
stroke
transient ischemic attack
aspirin
  • 4 views
  • 15 Feb, 2021
  • 1 location
REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients ( REMOTE-CAT)

Stroke is one of the leading causes of death worldwide and the main cause of incapacity. Currently, the only therapies for acute ischemic stroke (AIS) patients are the administration of

ischemia
arterial occlusion
alteplase
infarct
cerebral infarction
  • 1 views
  • 23 Jan, 2021
  • 2 locations
China Antihypertensive Trial in Acute Ischemic Stroke II

onset of an acute ischemic stroke will reduce the risk of composite case-fatality and major disability (modified Rankin Scale score 3) at three months compared to delayed antihypertensive treatment

  • 0 views
  • 27 Jan, 2021
  • 1 location
Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

care monitoring for patients with acute ischemic stroke of mild severity and without critical care needs after IV-tPA.

  • 0 views
  • 04 Jul, 2021
  • 26 locations
Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment

well as releasing oxidative stress, mitochondrial dysfunction and poststroke inflammation, dl-NBP has been widely applied in acute ischemic stroke as an anti-ischemic drug in China since 2002. While

  • 4 views
  • 26 Mar, 2021
  • 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke

Acute ischemic stroke (AIS) has the characteristics of high morbidity, high mortality, high disability rate and high recurrence rate. Progressive cerebral infarction (PIS) is a subtype of AIS

  • 0 views
  • 25 Jan, 2021
  • 6 locations